Annual Shareholders Equity
$6.57 B
-$2.17 B-24.85%
December 31, 2024
Summary
- As of February 26, 2025, BIO annual stockholders equity is $6.57 billion, with the most recent change of -$2.17 billion (-24.85%) on December 31, 2024.
- During the last 3 years, BIO annual shareholders equity has fallen by -$7.12 billion (-52.00%).
- BIO annual shareholders equity is now -52.00% below its all-time high of $13.69 billion, reached on December 31, 2021.
Performance
BIO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$6.57 B
-$918.56 M-12.27%
December 31, 2024
Summary
- As of February 26, 2025, BIO quarterly stockholders equity is $6.57 billion, with the most recent change of -$918.56 million (-12.27%) on December 31, 2024.
- Over the past year, BIO quarterly shareholders equity has dropped by -$2.48 billion (-27.42%).
- BIO quarterly shareholders equity is now -57.15% below its all-time high of $15.33 billion, reached on September 30, 2021.
Performance
BIO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BIO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | -27.4% |
| 3 y3 years | -52.0% | -31.7% |
| 5 y5 years | +14.2% | -31.7% |
BIO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | at low | -52.0% | at low |
| 5 y | 5-year | -52.0% | +14.2% | -57.1% | +14.2% |
| alltime | all time | -52.0% | >+9999.0% | -57.1% | >+9999.0% |
Bio-Rad Laboratories Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $6.57 B(-24.8%) | $6.57 B(-12.3%) |
| Sep 2024 | - | $7.49 B(+10.5%) |
| Jun 2024 | - | $6.78 B(-25.1%) |
| Mar 2024 | - | $9.05 B(+3.5%) |
| Dec 2023 | $8.74 B(-9.1%) | $8.74 B(+3.9%) |
| Sep 2023 | - | $8.42 B(-0.4%) |
| Jun 2023 | - | $8.45 B(-13.5%) |
| Mar 2023 | - | $9.76 B(+1.5%) |
| Dec 2022 | $9.62 B(-29.7%) | $9.62 B(+13.7%) |
| Sep 2022 | - | $8.45 B(-5.3%) |
| Jun 2022 | - | $8.92 B(-12.4%) |
| Mar 2022 | - | $10.18 B(-25.6%) |
| Dec 2021 | $13.69 B(+38.5%) | $13.69 B(-10.7%) |
| Sep 2021 | - | $15.33 B(+32.2%) |
| Jun 2021 | - | $11.59 B(+9.3%) |
| Mar 2021 | - | $10.61 B(+7.4%) |
| Dec 2020 | $9.88 B(+71.7%) | $9.88 B(+12.0%) |
| Sep 2020 | - | $8.83 B(+20.0%) |
| Jun 2020 | - | $7.35 B(+16.8%) |
| Mar 2020 | - | $6.29 B(+9.3%) |
| Dec 2019 | $5.76 B(+43.1%) | $5.76 B(+12.2%) |
| Sep 2019 | - | $5.13 B(-6.5%) |
| Jun 2019 | - | $5.49 B(+12.8%) |
| Mar 2019 | - | $4.86 B(+21.0%) |
| Dec 2018 | $4.02 B(+37.2%) | $4.02 B(-18.0%) |
| Sep 2018 | - | $4.90 B(+5.6%) |
| Jun 2018 | - | $4.64 B(+3.4%) |
| Mar 2018 | - | $4.49 B(+53.2%) |
| Dec 2017 | $2.93 B(+13.6%) | $2.93 B(+2.9%) |
| Sep 2017 | - | $2.85 B(+1.3%) |
| Jun 2017 | - | $2.81 B(+3.8%) |
| Mar 2017 | - | $2.71 B(+5.0%) |
| Dec 2016 | $2.58 B(+3.6%) | $2.58 B(-4.6%) |
| Sep 2016 | - | $2.70 B(+3.4%) |
| Jun 2016 | - | $2.61 B(+2.8%) |
| Mar 2016 | - | $2.54 B(+2.2%) |
| Dec 2015 | $2.49 B(+14.0%) | $2.49 B(+2.5%) |
| Sep 2015 | - | $2.43 B(+3.0%) |
| Jun 2015 | - | $2.36 B(+7.3%) |
| Mar 2015 | - | $2.20 B(+0.6%) |
| Dec 2014 | $2.19 B(-0.1%) | $2.19 B(+0.4%) |
| Sep 2014 | - | $2.18 B(-3.3%) |
| Jun 2014 | - | $2.25 B(+0.8%) |
| Mar 2014 | - | $2.23 B(+2.1%) |
| Dec 2013 | $2.19 B(+8.5%) | $2.19 B(+2.9%) |
| Sep 2013 | - | $2.12 B(+2.6%) |
| Jun 2013 | - | $2.07 B(+2.0%) |
| Mar 2013 | - | $2.03 B(+0.8%) |
| Dec 2012 | $2.02 B(+15.5%) | $2.02 B(+4.1%) |
| Sep 2012 | - | $1.93 B(+4.5%) |
| Jun 2012 | - | $1.85 B(+0.7%) |
| Mar 2012 | - | $1.84 B(+5.5%) |
| Dec 2011 | $1.74 B(+13.5%) | $1.74 B(+3.0%) |
| Sep 2011 | - | $1.69 B(-1.9%) |
| Jun 2011 | - | $1.73 B(+7.0%) |
| Mar 2011 | - | $1.61 B(+4.9%) |
| Dec 2010 | $1.54 B(+22.0%) | $1.54 B(+7.9%) |
| Sep 2010 | - | $1.42 B(+10.8%) |
| Jun 2010 | - | $1.29 B(+0.2%) |
| Mar 2010 | - | $1.28 B(+1.8%) |
| Dec 2009 | $1.26 B(+21.0%) | $1.26 B(+4.2%) |
| Sep 2009 | - | $1.21 B(+8.9%) |
| Jun 2009 | - | $1.11 B(+8.1%) |
| Mar 2009 | - | $1.03 B(-1.4%) |
| Dec 2008 | $1.04 B(+7.1%) | $1.04 B(-0.9%) |
| Sep 2008 | - | $1.05 B(-5.8%) |
| Jun 2008 | - | $1.11 B(+3.0%) |
| Mar 2008 | - | $1.08 B(+11.4%) |
| Dec 2007 | $971.69 M(+18.6%) | $971.69 M(+2.7%) |
| Sep 2007 | - | $946.34 M(+5.5%) |
| Jun 2007 | - | $896.80 M(+4.2%) |
| Mar 2007 | - | $860.66 M(+5.0%) |
| Dec 2006 | $819.54 M | $819.54 M(+4.4%) |
| Sep 2006 | - | $784.74 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $756.11 M(+7.6%) |
| Mar 2006 | - | $702.65 M(+6.8%) |
| Dec 2005 | $657.97 M(+10.2%) | $657.97 M(+1.4%) |
| Sep 2005 | - | $648.96 M(+3.2%) |
| Jun 2005 | - | $628.64 M(+0.7%) |
| Mar 2005 | - | $624.29 M(+4.6%) |
| Dec 2004 | $596.89 M(+20.4%) | $596.89 M(+7.8%) |
| Sep 2004 | - | $553.84 M(+1.7%) |
| Jun 2004 | - | $544.52 M(+5.1%) |
| Mar 2004 | - | $518.32 M(+4.5%) |
| Dec 2003 | $495.81 M(+29.4%) | $495.81 M(+7.9%) |
| Sep 2003 | - | $459.34 M(+2.4%) |
| Jun 2003 | - | $448.59 M(+8.4%) |
| Mar 2003 | - | $414.00 M(+8.1%) |
| Dec 2002 | $383.09 M(+34.9%) | $383.09 M(+7.5%) |
| Sep 2002 | - | $356.52 M(+4.6%) |
| Jun 2002 | - | $340.91 M(+11.8%) |
| Mar 2002 | - | $304.94 M(+7.4%) |
| Dec 2001 | $283.88 M(+16.0%) | $283.88 M(+4.2%) |
| Sep 2001 | - | $272.32 M(+6.2%) |
| Jun 2001 | - | $256.33 M(+3.7%) |
| Mar 2001 | - | $247.26 M(+1.1%) |
| Dec 2000 | $244.62 M(+11.1%) | $244.62 M(+7.0%) |
| Sep 2000 | - | $228.70 M(+2.9%) |
| Jun 2000 | - | $222.34 M(+1.5%) |
| Mar 2000 | - | $219.00 M(-0.5%) |
| Dec 1999 | $220.10 M(+2.7%) | $220.10 M(-6.0%) |
| Sep 1999 | - | $234.20 M(+2.4%) |
| Jun 1999 | - | $228.80 M(+3.6%) |
| Mar 1999 | - | $220.90 M(+3.1%) |
| Dec 1998 | $214.30 M(+8.9%) | $214.30 M(+1.1%) |
| Sep 1998 | - | $212.00 M(+0.8%) |
| Jun 1998 | - | $210.30 M(+1.4%) |
| Mar 1998 | - | $207.40 M(+5.4%) |
| Dec 1997 | $196.70 M(+7.2%) | $196.70 M(+1.0%) |
| Sep 1997 | - | $194.80 M(+0.2%) |
| Jun 1997 | - | $194.40 M(+3.6%) |
| Mar 1997 | - | $187.70 M(+2.3%) |
| Dec 1996 | $183.50 M(+16.8%) | $183.50 M(+1.4%) |
| Sep 1996 | - | $181.00 M(+4.0%) |
| Jun 1996 | - | $174.10 M(+4.7%) |
| Mar 1996 | - | $166.30 M(+5.9%) |
| Dec 1995 | $157.10 M(+21.0%) | $157.10 M(+3.8%) |
| Sep 1995 | - | $151.40 M(+2.9%) |
| Jun 1995 | - | $147.10 M(+5.1%) |
| Mar 1995 | - | $139.90 M(+7.8%) |
| Dec 1994 | $129.80 M(+17.7%) | $129.80 M(+3.3%) |
| Sep 1994 | - | $125.60 M(+3.6%) |
| Jun 1994 | - | $121.20 M(+3.1%) |
| Mar 1994 | - | $117.60 M(+6.6%) |
| Dec 1993 | $110.30 M(+3.0%) | $110.30 M(-1.4%) |
| Sep 1993 | - | $111.90 M(+0.7%) |
| Jun 1993 | - | $111.10 M(+0.4%) |
| Mar 1993 | - | $110.70 M(+3.4%) |
| Dec 1992 | $107.10 M(+18.0%) | $107.10 M(-0.8%) |
| Sep 1992 | - | $108.00 M(+2.5%) |
| Jun 1992 | - | $105.40 M(+10.7%) |
| Mar 1992 | - | $95.20 M(+4.8%) |
| Dec 1991 | $90.80 M(+12.0%) | $90.80 M(+2.7%) |
| Sep 1991 | - | $88.40 M(+2.9%) |
| Jun 1991 | - | $85.90 M(+0.5%) |
| Mar 1991 | - | $85.50 M(+5.4%) |
| Dec 1990 | $81.10 M(+17.7%) | $81.10 M(+5.1%) |
| Sep 1990 | - | $77.20 M(+0.8%) |
| Jun 1990 | - | $76.60 M(+3.1%) |
| Mar 1990 | - | $74.30 M(+7.8%) |
| Dec 1989 | $68.90 M(+15.8%) | $68.90 M(+3.6%) |
| Sep 1989 | - | $66.50 M(+3.3%) |
| Jun 1989 | - | $64.40 M(+8.2%) |
| Dec 1988 | $59.50 M(+18.8%) | $59.50 M(+18.8%) |
| Dec 1987 | $50.10 M(+15.7%) | $50.10 M(+15.7%) |
| Dec 1986 | $43.30 M(+44.8%) | $43.30 M(+44.8%) |
| Dec 1985 | $29.90 M(+58.2%) | $29.90 M(+58.2%) |
| Dec 1984 | $18.90 M | $18.90 M |
FAQ
- What is Bio-Rad Laboratories annual stockholders equity?
- What is the all time high annual shareholders equity for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual shareholders equity year-on-year change?
- What is Bio-Rad Laboratories quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly shareholders equity year-on-year change?
What is Bio-Rad Laboratories annual stockholders equity?
The current annual shareholders equity of BIO is $6.57 B
What is the all time high annual shareholders equity for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual stockholders equity is $13.69 B
What is Bio-Rad Laboratories annual shareholders equity year-on-year change?
Over the past year, BIO annual stockholders equity has changed by -$2.17 B (-24.85%)
What is Bio-Rad Laboratories quarterly stockholders equity?
The current quarterly shareholders equity of BIO is $6.57 B
What is the all time high quarterly shareholders equity for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly stockholders equity is $15.33 B
What is Bio-Rad Laboratories quarterly shareholders equity year-on-year change?
Over the past year, BIO quarterly stockholders equity has changed by -$2.48 B (-27.42%)